期刊文献+

系统性红斑狼疮合并医院内真菌感染的病原学分析与治疗 被引量:7

The pathogenic features and treatment of systemic lupus erythematosus complicated with nosocomial fungal infections
下载PDF
导出
摘要 目的探讨系统性红斑狼疮(SLE)合并医院内真菌感染的病原学特征、临床表现、易感因素、治疗和预后。方法回顾性分析1998年1月至2008年1月经微生物学检查证实的82例SLE合并医院内真菌感染患者资料。结果1525例SLE患者中,82例发生医院内真菌感染,发生率5.4%。占SLE医院感染总例数的17.9%(82/458)。感染部位常见为口腔(34%),下呼吸道(32%)和胃肠道(21%)。82例中共分离出真菌103株,最常见为念珠菌属(74.7%),其次为隐球菌(9.8%)和曲霉菌(5.8%)。易感因素为低蛋白血症、血白细胞减少、低补体血症,长期使用肾上腺皮质激素、免疫抑制剂和广谱抗生素以及侵入性操作等。抗真菌治疗单用氟康唑47例,制霉菌素7例,伏立康唑6例,伊曲康唑5例,两性霉素B5例,卡泊芬净1例,其余均为联合用药。本组治愈39例,好转23例,恶化3例,死亡17例,病死率达21%。结论念珠菌为常见致病菌。SLE合并医院内真菌感染病死率高。临床医生应高度警惕真菌感染,早期诊断及合理治疗有助于改善SLE患者预后。 Objective To explore the pathogenic features, clinical spectrum, risk factors, antifungal therapy and prognosis in systemic lupus erythematosus (fiLE) patients complicated with nosocomial fungal infections. Methods A review was performed of 82 SLE patients with nosocomial fungal infections in our hospital between Jan 1998 and Jan 2008. Results Of 1525 SLE patients, 82 (5.4 %) suffered nosocomial fungal infections. The infections most frequently involved oral cavity (34%), lower respiratory tract (32%) and gastrointestinal tract (21%). 113 fungal strains were isolated from the 82 cases. The most common pathogen was Candida (74.7%), followed by Cryptococcus (9.8%) and Aspergillus (5.8%). Hypoproteinemia, leukopenia, low serum complement level, invasive operation, long-term use of corticosteroids, immunosuppressants and broad-spectrum antibiotics were found to be risk factors. Antifungal therapy included single use of fluconazole (n=47), nystatin (n=7), voriconazole (n=6), itraconazole (n=5), amphotericin S (n=5), caspofungin (n=1) or certain combination of these agents in the remaining cases. Of all cases, 39 were cured, 23 improved, 3 worsened and 17 (21%) died. Conclusion Clinicians should be alerted against SLE with nosocomial fungal infections, which is most frequently caused by Candida and usually highly fatal. Early diagnosis and rational treatment could improve the prognosis.
出处 《中国药物与临床》 CAS 2008年第9期699-701,共3页 Chinese Remedies & Clinics
基金 广东省科技计划基金资助项目(2005B30701001)
关键词 红斑狼疮 系统性 医院感染 真菌 Lupus erythematosus, systemic Nosocomial infection Fungi
  • 相关文献

参考文献9

  • 1Cervera R, Khamashta MA, Font J, et al. Mobidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore),2003,82(5):299-308.
  • 2费允云,张奉春.系统性红斑狼疮患者死亡原因分析[J].中华风湿病学杂志,2008,12(3):187-191. 被引量:33
  • 3刘正印,盛瑞媛,李旭丽,李太生,王爱霞.院内真菌感染149例分析[J].中华医学杂志,2003,83(5):399-402. 被引量:153
  • 4Chen HS, Tsai WP, Leu HS, et al. Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology(Oxford),2007,46(3):539-544.
  • 5Al-Rayes H, Al-Swailem R, Arfin M, et al. Systemic lupus erythematosus and infections: a retrospective study in Saudis. Lupus, 2007,16(9):755-763.
  • 6余毅,谢福安,王丽萍,杨银泉,陈建,余英豪.狼疮性肾炎医院内真菌感染的临床分析[J].中华医院感染学杂志,2004,14(6):630-632. 被引量:6
  • 7董光富,叶任高,张晓,陈文莉.系统性红斑狼疮并发感染的流行病学研究[J].中华医院感染学杂志,2004,14(7):755-758. 被引量:31
  • 8Falagas ME, Manta KG, Betsi GI, et al. Infection-related morbi dity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol,2007,26(5):663-670.
  • 9Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity, 2005, 38(7):473-485.

二级参考文献38

  • 1杜斌,张海涛,陈德昌,刘大为,侯百东,熊雯,刘彤华,陈杰.3447例尸检病例的深部真菌感染分析[J].中华医学杂志,1996,76(5):352-354. 被引量:119
  • 2Bellomio V, Spindler A, Lucero E, et al. Systemic lupus erythematosus: mortality and survival in Argentina: a muhicenter study Lupus, 2000, 9: 377-381.
  • 3Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus (Part 1 ): entry variables as predictors of prognosis. Arthritis Rheum, 1982, 25: 601-611.
  • 4Abu-Shakra M, IJrowitz MB, Gladman DD, et al. Mortality study in systemic lupus erythematosus, Results from a single center. 1. Causes of death. J Rheumatol, 1995, 22: 1259-1264.
  • 5Abu-Shakra M, Gladman DD, IJrowitz MB, et al. Mortality stud- ies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev, 2004, 3: 418-420.
  • 6Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore), 2003, 82: 299-308.
  • 7Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol, 2001, 13: 345-351.
  • 8Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1000 patients. Medicine (Baltimore), 1999, 78: 167-175.
  • 9Jacobsen S, Petersen J, Ullman S, et al. Mortality and causes of deaths of 513 Danish patients with systemic lupus erythematosus, Scand J Rheumatoi, 1999, 28: 75-80.
  • 10Cook RJ, Gladman DD, Pericak D, et al. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol, 2000, 27: 1892- 1895.

共引文献215

同被引文献62

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部